The 2011 Leading Pharmaceutical Companies Strategic Directions

October 2010 | 45 pages | ID: L8CE83A8612EN
Venture Planning Group

Abstracts

Global PDF: US$ 3,900.00

For each company, the report provides insightful strategic assessments, including:

• Major strengths and weaknesses.
• Business, new product development, and marketing objectives and strategies.
• Anticipated acquisitions, joint ventures and divestitures.

The companies analyzed in the report:

        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   Wyeth

Contains 45 pages